Why Repligen Corporation (RGEN) stock moved
Repligen Corporation (RGEN) shares fell 3.2% to $176.27 as of August 30, 2026, a moderate decline from the prior close of $182.03. BestStocks flagged the session as a major change for RGEN. The move is tied to price move up. Below, we break down what changed for RGEN, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
RGEN fell 3.2% to $176.27
RGEN fell 3.2% in its latest session, moving from $182.03 to $176.27.
What it means for Repligen Corporation investors
For Repligen Corporation investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; Repligen Corporation (RGEN) moved +4.75% from $137.41 to $143.94 on 2026-07-09. Weighing against that: Material negative event; Negative session, down 3.2%. Wall Street's consensus price target sits at $152.00, implying -13.8% downside from $176.27. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality low (47/100). With earnings roughly 65 days out, the next report is the most likely near-term test of the move.
RGEN price reaction
RGEN last traded at $176.27, down $5.76 (-3.16%) from the previous close of $182.03. The session traded on 0.7× average volume (below avg), so participation was unremarkable.
Bullish and bearish analyst opinions on Repligen Corporation (RGEN)
The consensus analyst price target on Repligen Corporation (RGEN) is $152.00, 13.8% below the recent $176.27. Over the past 90 days analysts logged 1 upgrade, 4 maintains, and 0 downgrades. Here is how the bullish and bearish cases on RGEN line up.
The bullish case
- 1 analyst upgrade in the past 90 days, most recently Benchmark to Buy (2026-07-07).
- Positive price momentum.
- Repligen Corporation (RGEN) moved +4.75% from $137.41 to $143.94 on 2026-07-09.
The bearish case
- The consensus analyst price target of $152.00 sits 13.8% below the recent $176.27, so the average target sees limited room to run.
- The most bearish analyst target is $142.00 (-19.4%).
- Material negative event.
- Negative session, down 3.2%.
- Repligen Corporation (RGEN) moved -5.84% from $145.49 to $136.99 on 2026-07-21.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 30, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for RGEN
Frequently asked questions about RGEN
Why did Repligen Corporation (RGEN) stock move?
RGEN fell 3.2% to $176.27. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did RGEN stock fall?
RGEN lost 3.16% ($5.76) versus the prior close of $182.03, last trading at $176.27 on 0.7× average volume.
When is Repligen Corporation's next earnings date?
RGEN's next earnings report is estimated for 2026-11-03 — about 65 days away.
What is the analyst price target for RGEN?
The consensus analyst price target for RGEN is $152.00, about 13.8% below the current $176.27. Over the past 90 days, analysts recorded 1 upgrade, 4 maintains, and 0 downgrades.
How BestStocks tracks RGEN
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for RGEN, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 30, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.